DS
SLDB icon

David Shaw’s Solid Biosciences SLDB Stock Holding History

David Shaw’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
222,789
+94,441
+74% +$716K ﹤0.01% 3106
2026
Q1 		$924K Buy
128,348
+88
+0.1% +$565 ﹤0.01% 3493
2025
Q4 		$723K Buy
+128,260
New +$695K ﹤0.01% 3735
2025
Q1 		– Sell
-51,972
Closed -$208K – 4703
2024
Q4 		$208K Buy
+51,972
New +$285K ﹤0.01% 4068
2021
Q4 		– Sell
-1,312
Closed -$47K – 5689
2021
Q3 		$47K Sell
1,312
-3,227
-71% -$137K ﹤0.01% 4830
2021
Q2 		$249K Buy
4,539
+3,440
+313% +$227K ﹤0.01% 4359
2021
Q1 		$91K Sell
1,099
-13,992
-93% -$1.55M ﹤0.01% 3938
2020
Q4 		$1.72M Sell
15,091
-4,478
-23% -$283K ﹤0.01% 2650
2020
Q3 		$596K Sell
19,569
-4,326
-18% -$166K ﹤0.01% 3137
2020
Q2 		$1.05M Buy
23,895
+3,474
+17% +$144K ﹤0.01% 2895
2020
Q1 		$732K Buy
20,421
+2,787
+16% +$138K ﹤0.01% 2977
2019
Q4 		$1.18M Buy
17,634
+12,466
+241% +$1.38M ﹤0.01% 2871
2019
Q3 		$802K Buy
+5,168
New +$585K ﹤0.01% 2943
2018
Q4 		– Sell
-2,302
Closed -$1.63M – 3968
2018
Q3 		$1.63M Sell
2,302
-1,168
-34% -$734K ﹤0.01% 2346
2018
Q2 		$1.85M Buy
3,470
+1,867
+116% +$574K ﹤0.01% 2276
2018
Q1 		$180K Buy
+1,603
New +$541K ﹤0.01% 3346

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

David Shaw's SLDB Position: Q2 2026 in Review

David Shaw increased its Solid Biosciences (SLDB) stake by 74% in Q2 2026, buying an estimated $716K and bringing the position to 222,789 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

David Shaw first reported a position in SLDB in Q1 2018 and has held it in 16 quarters since. 155 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • David Shaw held 222,789 shares of Solid Biosciences worth $2.23M as of Q2 2026.
  • David Shaw bought 94,441 Solid Biosciences shares in Q2 2026, an estimated $716K.
  • Solid Biosciences made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3106 holding.
  • David Shaw first reported a position in Solid Biosciences in Q1 2018 and has held it in 16 quarters since.
  • 155 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.